Manager × security

DAFNA Capital Management LLC XBI holdings history

SS SPDR S&P BIOTECH ETF · CUSIP 78464A870 · CIK 1389933

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, DAFNA Capital Management LLC reported 196.50K XBI (shares), valued at $31.10M, or 5.93% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
5.93%
Shares
196.50K
196,505
Reported value
$31.10M
USD

Shares decreased 38.30%; reported value decreased 23.56%, and weight changed -3.32 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 20265.93%196,505SEC filing ↗Filed Aug 14, 2026
Q1 20269.25%318,505SEC filing ↗Filed May 15, 2026
Q4 20259.53%336,505SEC filing ↗Filed Feb 17, 2026
Q3 20259.94%401,505SEC filing ↗Filed Nov 14, 2025
Q2 20259.51%415,505SEC filing ↗Filed Aug 14, 2025
Q1 20259.30%404,505SEC filing ↗Filed May 15, 2025
Q4 20249.10%397,505SEC filing ↗Filed Feb 14, 2025
Q3 20249.37%401,505SEC filing ↗Filed Nov 14, 2024
Q2 20249.86%445,005SEC filing ↗Filed Aug 14, 2024
Q1 20249.31%431,215SEC filing ↗Filed May 15, 2024
Q4 202310.36%484,000SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 202310.36%484,000$43.22MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 20249.31%431,215$40.92MShares decreased 10.91%; reported value decreased 5.32%, and weight changed -1.05 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 20249.86%445,005$41.26MShares increased 3.20%; reported value increased 0.83%, and weight changed +0.55 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2024
Q3 20249.37%401,505$39.67MShares decreased 9.78%; reported value decreased 3.85%, and weight changed -0.49 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2024
Q4 20249.10%397,505$35.80MShares decreased 1.00%; reported value decreased 9.75%, and weight changed -0.27 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 14, 2025
Q1 20259.30%404,505$32.81MShares increased 1.76%; reported value decreased 8.36%, and weight changed +0.20 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 20259.51%415,505$34.46MShares increased 2.72%; reported value increased 5.04%, and weight changed +0.21 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2025
Q3 20259.94%401,505$40.23MShares decreased 3.37%; reported value increased 16.75%, and weight changed +0.43 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 14, 2025
Q4 20259.53%336,505$41.03MShares decreased 16.19%; reported value increased 1.99%, and weight changed -0.41 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 17, 2026
Q1 20269.25%318,505$40.68MShares decreased 5.35%; reported value decreased 0.85%, and weight changed -0.28 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 20265.93%196,505$31.10MShares decreased 38.30%; reported value decreased 23.56%, and weight changed -3.32 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
DAFNA Capital Management LLC · SS SPDR S&P BIOTECH ETF

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1389933","quarter":"2026Q2","cusip":"78464A870"}

get_institutional_manager_history
{"cik":"1389933","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.